Pressure ulcer of contiguous site of back, buttock and hip, stage 3
ICD-10 L89.43 is a billable code used to indicate a diagnosis of pressure ulcer of contiguous site of back, buttock and hip, stage 3.
L89.43 refers to a stage 3 pressure ulcer located on contiguous sites of the back, buttock, and hip. Clinically, a stage 3 pressure ulcer is characterized by full-thickness skin loss, which may extend into the subcutaneous tissue but does not involve underlying fascia, muscle, or bone. The ulcer may present with slough or necrotic tissue, and the depth can vary based on the anatomical site. The back, buttock, and hip are common areas for pressure ulcers due to prolonged pressure, especially in individuals with limited mobility or those who are bedridden. Disease progression can lead to further complications, including infection, which may necessitate surgical intervention. Diagnostic considerations include a thorough assessment of the ulcer's size, depth, and surrounding tissue condition, along with patient history to identify risk factors such as immobility, malnutrition, and comorbidities. Proper staging and documentation are crucial for effective treatment planning and reimbursement.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L89.43 covers stage 3 pressure ulcers specifically located on the back, buttock, and hip. These ulcers are characterized by full-thickness skin loss and may have necrotic tissue but do not involve underlying structures.
L89.43 should be used when a pressure ulcer is confirmed as stage 3 on the specified anatomical sites. It is important to differentiate it from stage 2 (L89.42) and stage 4 (L89.44) ulcers based on the depth of tissue loss.
Documentation should include a detailed description of the ulcer's size, depth, and characteristics, along with patient risk factors and treatment plans. Regular assessments and updates on healing progress are also essential.
